Biota Pharmaceuticals, Inc.

40 articles about Biota Pharmaceuticals, Inc.

• Biota Pharmaceuticals, Inc. To Participate In The Guggenheim Securities 3rd Annual Boston Healthcare Conference

  12/14/2015

• Biota Pharmaceuticals, Inc. To Present At Stifel 2015 Healthcare Conference

  11/12/2015

• Biota Pharmaceuticals, Inc. Reports First Quarter Fiscal Year 2016 Financial Results

  11/6/2015

• Biota Pharmaceuticals, Inc. Announces Appointment Of Mark P. Colonnese As Chief Financial Officer

  11/2/2015

• Biota Pharmaceuticals, Inc. To Host Conference Call To Report First Quarter Fiscal Year 2016 Financial Results On November 6, 2015

  10/30/2015

• Biota Pharmaceuticals, Inc. To Present At Ladenburg Thalmann 2015 Healthcare Conference

  9/23/2015

• Biota Pharmaceuticals, Inc. Appoints Armando Anido And Michael Dunne, M.D. To Its Board Of Directors

  9/22/2015

• Biota Pharmaceuticals, Inc. Reports Fourth Quarter And Fiscal Year 2015 Financial Results

  9/11/2015

• Biota Pharmaceuticals, Inc. To Host Conference Call To Report Fourth Quarter And Fiscal Year 2015 Financial Results On September 11, 2015In Metastatic Pancreatic Cancer

  9/8/2015

• Biota Pharmaceuticals, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference

  9/2/2015

• Biota Pharmaceuticals, Inc. Advances RSV Program With Commencement Of Dosing In Phase I Trial For Direct-Acting Antiviral BTA585

  8/20/2015

• Biota Pharmaceuticals, Inc.' CEO Dr. Joseph Patti Interviewed By The Life Sciences Report

  7/16/2015

• Biota Pharmaceuticals, Inc. Completes Acquisition Of Anaconda Pharma

  6/3/2015

• Biota Pharmaceuticals, Inc. Reports Third Quarter Fiscal Year 2015 Financial Results

  5/7/2015

• Biota Pharmaceuticals, Inc. To Host Conference Call To Report Third Quarter Fiscal Year 2015 Financial Results

  5/1/2015

• Biota Pharmaceuticals, Inc. To Present At The 27th Annual Roth Conference

  3/4/2015

• Biota Pharmaceuticals, Inc. Commences Dosing In Vapendavir SPIRITUS Phase IIb Trial

  3/3/2015

• Biota Pharmaceuticals, Inc. Grabs Anaconda Pharma in $38 Million Deal

  2/26/2015

• Biota Pharmaceuticals, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results

  2/5/2015

• Biota Pharmaceuticals, Inc. To Present At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/4/2015